Kronos Worldwide
KRO
7.81
+0.03
+0.39%
Kronos Worldwide
US · KRO
#3319 by market cap
7.81
+0.03
+0.39%
Live - 5344 symbols - heartbeat 332s ago
· 2026-10-08 10:04
Pre-market
7.75
-0.39%
After-hours
7.78
0.00%
- Market cap
- 898.91M
- P/E (TTM)i
- -8.22
- P/Bi
- 1.20
- EPSi
- -0.96
- Div yieldi
- 2.56%
- 52W posi
- 75%
Reader sentiment
Are you bullish or bearish on KRO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.60, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.47% YoY
Margins
- Gross margin
- 11.46%
- Operating margin
- -2.25%
- Net margin
- -5.96%
Key ratios & quality
- Enterprise valuei
- 1.43B
- Altman Z-Scorei
- 1.60
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.66B | 1.73B | 1.64B | 1.94B | 1.93B | 1.67B | 1.89B | 1.86B |
| Gross profit | 562.20M | 386.20M | 351.20M | 446.20M | 391.10M | 164.90M | 359.30M | 213.00M |
| Selling & admin expenses | 242.80M | 243.30M | 232.40M | 248.90M | 231.30M | 193.20M | 211.60M | 229.20M |
| Research & development | -- | -- | -- | -- | -- | 18.00M | 14.00M | 16.00M |
| Operating profit | 320.20M | 143.80M | 120.20M | 185.50M | 148.10M | -57.40M | 121.30M | -41.90M |
| Pretax profit | 293.80M | 121.10M | 80.00M | 153.40M | 133.90M | -72.90M | 149.60M | -97.40M |
| Tax | 88.80M | 34.00M | 16.10M | 40.50M | 29.40M | -23.80M | 63.40M | 13.50M |
| Net profit | 205.00M | 87.10M | 63.90M | 112.90M | 104.50M | -49.10M | 86.20M | -110.90M |
| Basic EPS | 2 | 1 | 1 | 1 | 1 | 0 | 1 | -1 |
| Diluted EPS | 1.77 | 0.75 | 0.55 | 0.98 | 0.90 | -0.43 | 0.75 | -0.96 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 489.80M | 494.40M | 456.90M | 418.30M | 509.80M | 558.10M |
| Gross profit | 106.80M | 62.80M | 47.00M | -3.60M | 83.30M | 102.80M |
| Selling & admin expenses | 61.60M | 62.10M | 61.60M | 43.90M | 63.60M | 64.50M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 42.70M | -2.00M | -17.30M | -65.30M | 18.00M | 38.10M |
| Pretax profit | 25.70M | -5.70M | -29.10M | -88.30M | -2.00M | 22.90M |
| Tax | 7.60M | 3.50M | 7.90M | -5.50M | 2.80M | 7.70M |
| Net profit | 18.10M | -9.20M | -37.00M | -82.80M | -4.80M | 15.20M |
| Basic EPS | 0 | 0 | 0 | -1 | 0 | 0 |
| Diluted EPS | 0.16 | -0.08 | -0.32 | -0.72 | -0.04 | 0.13 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.20B | 1.22B | 1.22B | 1.26B | 1.24B | 1.12B | 1.11B | 994.50M |
| Cash & ST investments | 373.30M | 390.80M | 355.30M | 406.00M | 327.80M | 194.70M | 106.70M | 33.20M |
| Inventory | 497.90M | 503.00M | 519.00M | 432.30M | 608.70M | 564.60M | 656.70M | 628.60M |
| Total assets | 1.90B | 1.97B | 2.04B | 2.01B | 1.93B | 1.84B | 1.91B | 1.82B |
| Total current liabilities | 233.40M | 270.60M | 260.20M | 288.80M | 326.70M | 370.80M | 476.60M | 368.80M |
| Short-term debt | 1.50M | 7.70M | 7.40M | 5.10M | 4.90M | 3.90M | 81.80M | 4.20M |
| Long-term debt | 455.10M | 444.00M | 486.70M | 449.80M | 424.10M | 440.90M | 429.10M | 557.40M |
| Total liabilities | 1,058,300,000.00 | 1,149,700,000.00 | 1,240,200,000.00 | 1,142,600,000.00 | 977,200,000.00 | 1,029,700,000.00 | 1,096,500,000.00 | 1,065,700,000.00 |
| Total equity | 839.80M | 816.10M | 796.50M | 870.20M | 957.20M | 808.30M | 817.00M | 751.10M |
| Retained earnings | -136.20M | -132.50M | -151.80M | -122.10M | -105.40M | -242.00M | -211.00M | -344.90M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.13B | 1.09B | 1.07B | 994.50M | 988.50M | 942.60M |
| Cash & ST investments | 20.50M | 18.90M | 27.70M | 33.20M | 25.70M | 26.60M |
| Inventory | 699.80M | 683.50M | 659.10M | 628.60M | 549.30M | 498.30M |
| Total assets | 1.95B | 1.94B | 1.91B | 1.82B | 1.80B | 1.74B |
| Total current liabilities | 430.30M | 390.20M | 279.20M | 368.80M | 311.00M | 285.80M |
| Short-term debt | 85.10M | 92.10M | 4.40M | 4.20M | 3.90M | 3.90M |
| Long-term debt | 476.00M | 501.40M | 626.20M | 557.40M | 602.70M | 569.60M |
| Total liabilities | 1,099,000,000.00 | 1,093,600,000.00 | 1,105,000,000.00 | 1,065,700,000.00 | 1,053,300,000.00 | 993,000,000.00 |
| Total equity | 847.00M | 846.80M | 804.70M | 751.10M | 745.00M | 751.00M |
| Retained earnings | -198.70M | -213.60M | -256.40M | -344.90M | -355.50M | -346.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 188.50M | 160.30M | 102.50M | 206.50M | 81.70M | 5.50M | 72.50M | 2.50M |
| Depreciation & amortization | 49.70M | 54.90M | 64.60M | 57.90M | 56.20M | 53.10M | 64.40M | 64.80M |
| Free cash flow | 132.20M | 105.20M | 39.70M | 147.90M | 18.50M | -41.90M | 43.00M | -40.40M |
| Dividends paid | -78.80M | -83.40M | -83.20M | -83.20M | -87.80M | -87.50M | -55.20M | -23.00M |
| Stock buybacks / issuance | -- | -3.00M | -1.00M | -200.00K | -2.30M | -2.90M | 0 | 0 |
| Ending cash balance | 374.70M | 392.30M | 362.00M | 412.60M | 334.60M | 202.10M | 114.70M | 42.50M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -102.40M | 20.70M | -7.90M | 92.10M | -51.30M | 53.30M |
| Depreciation & amortization | 14.90M | 16.10M | 16.80M | 17.00M | 16.60M | 16.90M |
| Free cash flow | -114.40M | 32.70M | -40.60M | 81.90M | -61.50M | 63.50M |
| Dividends paid | -5.80M | -5.70M | -5.80M | -5.70M | -5.80M | -5.70M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 28.60M | 27.70M | 36.40M | 42.50M | 33.60M | 34.50M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 25.72 | 10.52 | 7.93 | 13.55 | 11.44 | -5.56 | 10.61 | -14.14 |
| ROA %i | 11.01 | 4.51 | 3.19 | 5.58 | 5.29 | -2.60 | 4.60 | -5.95 |
| ROIC %i | 17.01 | 7.40 | 5.97 | 9.59 | 8.29 | -3.16 | 8.85 | -5.24 |
| 5-year avg ROE %i | 16.23 | 16.02 | 23.19 | 23.88 | 13.83 | 7.57 | 7.59 | 3.18 |
| EBIT margin %i | 18.85 | 8.08 | 6.04 | 8.92 | 7.81 | -3.35 | 10.20 | -2.39 |
| FCF / sales %i | 7.95 | 6.08 | 2.42 | 7.63 | 0.96 | -- | 2.28 | -- |
| Current ratioi | 5.15 | 4.51 | 4.68 | 4.36 | 3.80 | 3.01 | 2.32 | 2.70 |
| Quick ratioi | 2.94 | 2.59 | 2.61 | 2.72 | 1.78 | 1.37 | 0.84 | 0.87 |
| Debt / assetsi | 24.06 | 24.11 | 25.18 | 23.39 | 23.08 | 25.21 | 27.59 | 31.78 |
| LT debt / equityi | 54.19 | 57.13 | 63.47 | 53.50 | 46.12 | 56.85 | 54.61 | 76.30 |
| Interest coveragei | 16.07 | 7.48 | 5.21 | 8.83 | 8.92 | -3.26 | 4.49 | -0.84 |
| Revenue CAGR (3Y) %i | 7.21 | 8.26 | -1.77 | 5.28 | 3.70 | 0.56 | -0.91 | -1.24 |
| Net income CAGR (3Y) %i | -- | 26.23 | -43.51 | -18.03 | 6.26 | -- | -8.60 | -- |
| FCF CAGR (3Y) %i | 197.91 | 42.18 | -42.77 | 3.81 | -43.97 | -- | -33.75 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.87 | 8.33 | -5.00 | -14.14 | -16.81 | -13.69 |
| ROA %i | 5.31 | 3.75 | -2.16 | -5.95 | -7.15 | -5.94 |
| ROIC %i | 9.69 | 7.73 | -0.20 | -5.24 | -7.23 | -5.42 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.01 | 9.42 | 3.06 | -2.39 | -3.69 | -2.03 |
| FCF / sales %i | -- | -- | -- | -- | 0.67 | 2.23 |
| Current ratioi | 2.62 | 2.79 | 3.83 | 2.70 | 3.18 | 3.30 |
| Quick ratioi | 0.87 | 0.94 | 1.30 | 0.87 | 1.29 | 1.47 |
| Debt / assetsi | 29.71 | 31.47 | 33.88 | 31.78 | 34.56 | 33.75 |
| LT debt / equityi | 58.21 | 61.23 | 79.87 | 76.30 | 82.90 | 77.86 |
| Interest coveragei | 4.61 | 3.69 | 1.13 | -0.84 | -1.25 | -0.69 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Manufacture and sale of titanium dioxide pigments (TiO2) and related by-products100.00%
Quote time 2026-10-08 10:04:16 · For reference only, not investment advice and not tailored to your situation.